By Elena Vardon LungLife AI shares fell after the group flagged delays in the clinical validation study for its LungLB test. At 0745 GMT, shares were down 15.
LungLife AI Inc - California-based developer of clinical diagnostic solutions designed to address the early detection of lung cancer - Publishes performance results for blood-based LungLB test from a. | June 6, 2023
LungLife AI Inc on Tuesday said that it has completed enrolment for its prospective validation study of LungLB.
LungLife is a California-based developer of clinical diagnostic solutions designed to. | May 23, 2023